[{"Assets_0_Q2_USD":55163000000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":3473000000.0,"NetIncomeLoss_1_Q2_USD":1432000000.0,"NetIncomeLoss_2_Q2_USD":3142000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":1636000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":1635000000.0,"StockholdersEquity_0_Q2_USD":16049000000.0,"EarningsPerShareBasic_1_Q2_USD":0.88,"EarningsPerShareBasic_2_Q2_USD":1.92,"Ticker":"BMY","CIK":"14272","name":"BRISTOL MYERS SQUIBB CO","OfficialName":"Bristol-Myers Squibb Company Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"162365472986.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20190725"}]